CADD-Solis VIP ambulatory Infusion Pumps, Model 2120 (21-2120, 21-2125, and 21-2127) Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

The CADD Solis VIP Ambulatory Infusion Pump is indicated for the following uses: " For intravenous, intraarterial, subcutaneous, intraperitoneal, perineural, surgical site, epidural space, or subarachnoid space infusion.

Smiths medical issued an URGENT MEDICAL DEVICE CORRECTION notice to its consignees on 02/27/2024 via letter distributed using traceable means. The notice explained the issues affecting the devices, potential risks, and requested the following: "Required Actions for Users: 1. Locate all affected pumps in your possession and ensure all users or potential users of these devices are immediately made aware of this notification and proposed mitigations. 2. Complete and return the attached Response Form to [email protected] within ten days of receipt to acknowledge your understanding of this notification, even if you do not have the affected product. 3. DISTRIBUTORS: If you have distributed potentially affected products to your customers, please immediately forward this notice to them. Request that they complete the response form and return it to [email protected] Follow up Actions by Smiths Medical: Smiths Medical is sending this notification to all affected CADD-Solis customers and is addressing the issues described in this notice through software updates. Smiths Medical will contact you to schedule the implementation of the software updates." For questions contact: 1. Additional information or technical assistance: [email protected]; 1-800-241-4002, option 3, 4 (M-F, 8:00 am 6:00 pm CT) 2. Questions about this Field Correction Notice: icumed.custhelp.com/app/market-action